Search for: "Shire USA" Results 21 - 40 of 40
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Oct 2016, 10:00 pm by Dan Flynn
Bernie Shire of Meat+Poultry Magazine got an interview with Almanza, later on Sept. 19. [read post]
5 May 2010, 4:46 am
Taro Pharmaceutical USA Inc. et al (Patent Docs) Viagra (Sildenafil) – Brazil patents to expire 1 year early? [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
11 Aug 2014, 4:24 am by Ben
But the actual act of cracking down on that unlicensed music, a seemingly necessary move to "avoid trouble from the litigious music industry", is here to stay.Ronald Reagan: Official Portrait, 1981Author Craig Shirely, an expert on former US president Ronald Reagan, is threatening to sue another author and biographer, Rick Perlstein, for copyright infringement for  his new Reagan book, The Invisible Bridge, seeking that the publisher of Perlstein's book pulp all… [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
24 Jan 2012, 6:34 pm by FDABlog HPM
  Akorn’s ANDA, which FDA has not yet tentatively approved, contains a Paragraph IV certification to the ‘269 patent; however, according to the court, non-party Teva Pharmaceuticals USA, Inc. [read post]
13 Jul 2011, 3:04 am by Marie Louise
(BIOtechNOW) US: PTO agrees to reexamine broad codon-optimization patents (Holman’s Biotech IP Blog) US: Inherently incomprehensible: Does the CAFC’s view of inherency in In Re Kao spell the end of second medical use patents in the USA? [read post]
6 Apr 2011, 12:18 am by Marie Louise
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog)  Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and… [read post]
22 Jul 2011, 9:14 am by Steve Davies
Taylor Association of Fish & Wildllife Agencies 06/17/2011 Erin Wiedower Akuo Energy USA 06/17/2011 Shannon Deaton NC Wildlife Resources Commission 06/17/2011 Robyn Kullas NexGen Energy Partners, LLC 06/17/2011 Kimberlee Smith Centera Buffalo Gap Wind Farm2 06/17/2011 Joe Stevens AES Wind Generation 06/17/2011 Bart Rossi AES Wilson Creek Wind, LLC 06/17/2011 Michael Azeka Sand Ridge Wind Farm, LLC 06/17/2011 S. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
22 Dec 2010, 12:39 pm by Bexis
  That last point, the runaway jury awarding punitive damages on its own volition, particularly troubles us, because in Phillip Morris USA v. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Jun 2011, 12:46 pm by Bexis
It was the last blank space on the legal map – the only state with no precedent whatsoever. [read post]